Quinn Opportunity Partners »

Cerevel Therapeutics Hldng I shares owned by Quinn Opportunity Partners

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Quinn Opportunity Partners from 13F filings

Historical chart of Quinn Opportunity Partners investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Quinn Opportunity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Quinn Opportunity Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $205k 5.0k 40.89

More positions owned by Quinn Opportunity Partners

Biontech Se- Sponsored Ads (BNTX)
Capri Holdings SHS (CPRI)
Peloton Interactive Inc-a Cl A Com (PTON)
Starbucks Corporation (SBUX)
Verizon Communications (VZ)
Hubspot (HUBS)
Alibaba Group Holding-sp Sponsored Ads (BABA)
CVS Caremark Corporation (CVS)
Molson Coors Beverage Co - B CL B (TAP)
General Motors Company (GM)
Meta Platforms Inc-class A Cl A (META)
Philip Morris International (PM)
Zoom Video Communications-a Cl A (ZM)
Natwest Group Plc - Spons Adr (NWG)
At&t (T)

View all positions for Quinn Opportunity Partners

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
Vanguard Group
BlackRock
State Street Corporation
Millennium Management
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
LMR Partners
Marshall Wace
Alliancebernstein
Geode Capital Management
Citigroup

View all funds holding Cerevel Therapeutics Hldng I